V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 330008018 | 330004809 | null | 61.4 | Neo-adjuvant (N) | 2016-02-07 | 2016-02-07 | Cetuximab + Radiotherapy Maint | N | N | 330013871 | CETUXIMAB + RT |
| 330008019 | 330008623 | 1.58 | null | Palliative (P) | 2017-06-20 | 2017-06-28 | BENDAMUSTINE + RITUXIMAB | N | N | 330013886 | BENDAMUSTINE + RITUXIMAB |
| 330008020 | 330004810 | null | 90 | Curative (C) | 2016-05-29 | 2016-07-10 | EURAMOS TRIAL | null | Y | 330013886 | EURAMOS TRIAL |
| 330008021 | 330004811 | null | 50 | Adjuvant (A) | 2014-07-27 | 2014-12-17 | EURAMOS TRIAL | N | N | 330013895 | EURAMOS TRIAL |
| 330008022 | 330011816 | 1.62 | null | Curative (C) | 2013-09-14 | 2013-09-14 | EURAMOS TRIAL | 02 | N | 330013907 | EURAMOS TRIAL |
| 330008023 | 330011816 | 1.55 | null | Adjuvant (A) | 2016-10-28 | 2017-03-10 | CARBOPLATIN + RT | N | N | 330013907 | CARBOPLATIN + RT |
| 330008024 | 330004814 | 1.73 | 99 | Neo-adjuvant (N) | 2017-08-22 | 2017-08-22 | Carboplatin + Paclitaxel (3 weekly) | 02 | N | 330013921 | CARBOPLATIN + PACLITAXEL |
| 330008027 | 330004821 | 0 | 63.1 | Curative (C) | 2017-09-14 | 2017-09-14 | CARBOPLATIN + RT | 2 | N | 330013942 | CARBOPLATIN + RT |
| 330008028 | 330004822 | 0 | 51.7 | Curative (C) | 2017-07-14 | 2017-08-25 | CARBOPLATIN + RT | N | null | 330013957 | CARBOPLATIN + RT |
| 330008029 | 330004823 | 1.62 | 55.6 | Curative (C) | 2013-11-18 | 2014-04-03 | ALL UKALL2011 Maintenance A1 | 2 | N | 330013959 | UKALL2011 |
| 330008030 | 330008631 | null | 72 | Palliative (P) | 2017-08-12 | 2017-09-20 | Carboplatin + Etoposide IV 3 day | N | Y | 330013959 | CARBOPLATIN + ETOPOSIDE |
| 330008031 | 330004825 | null | 67.5 | Neo-adjuvant (N) | 2014-08-02 | 2014-08-02 | CISPLATIN + DOCETAXEL + FLUOROURACIL | Y | N | 330013974 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 330008032 | 330004826 | 1.72 | 82.2 | Palliative (P) | 2013-07-18 | 2013-07-18 | Carboplatin + Paclitaxel (weekly) | N | N | 330013979 | CARBOPLATIN + PACLITAXEL |
| 330008036 | 330004835 | null | 69.9 | Curative (C) | 2015-04-05 | 2015-06-18 | VAI (Ifos 3g/m2) | 02 | N | 330014063 | VAI |
| 330008038 | 330004836 | 1.58 | 76.1 | null | 2016-10-29 | 2016-11-12 | VAI (Ifos 3g/m2) | 2 | N | 330014088 | VAI |
| 330008039 | 330004836 | 1.7 | 50.7 | Palliative (P) | 2015-06-19 | 2015-07-12 | CARBOPLATIN + ETOPOSIDE | 2 | N | 330014088 | CARBOPLATIN + ETOPOSIDE |
| 330008040 | 330004836 | null | 84.2 | Palliative (P) | null | 2015-11-28 | Carboplatin + Paclitaxel (3 weekly) | N | null | 330014088 | CARBOPLATIN + PACLITAXEL |
| 330008041 | 330004837 | 1.05 | 76.6 | Neo-adjuvant (N) | 2016-08-05 | 2016-08-17 | EURAMOS TRIAL | N | N | 330014124 | EURAMOS TRIAL |
| 330008042 | 330008640 | 1.47 | 72.8 | Curative (C) | 2014-08-20 | 2014-08-20 | CARBOPLATIN + ETOPOSIDE | 2 | N | 330014129 | CARBOPLATIN + ETOPOSIDE |
| 330008043 | 330008640 | null | 55.6 | Not known (9) | null | 2013-04-04 | CARBOPLATIN + ETOPOSIDE | null | null | 330014129 | CARBOPLATIN + ETOPOSIDE |
| 330008044 | 330004839 | null | null | Palliative (P) | 2014-07-15 | 2014-07-15 | Bendamustine+Rituximab(Sub Courses) | 02 | N | 330014135 | BENDAMUSTINE + RITUXIMAB |
| 330008045 | 330004839 | 1.69 | null | Palliative (P) | 2016-10-02 | 2016-10-08 | CARBOPLATIN + PACLITAXEL | N | N | 330014135 | CARBOPLATIN + PACLITAXEL |
| 330008047 | 330008643 | 0 | 82.5 | Curative (C) | 2014-01-29 | 2014-02-02 | EURAMOS TRIAL | N | N | 330014150 | EURAMOS TRIAL |
| 330008048 | 330010685 | 1.77 | 77.7 | Disease modification (D) | 2014-01-26 | 2014-01-26 | BENDAMUSTINE + RITUXIMAB | 02 | N | 330014152 | BENDAMUSTINE + RITUXIMAB |
| 330008049 | 330010685 | null | 54 | Palliative (P) | null | 2015-06-15 | ALL UKALL2011 Cap Int Maint C PAsp | N | null | 330014152 | UKALL2011 |
| 330008050 | 330004843 | 1.53 | null | Palliative (P) | 2014-03-12 | 2014-03-24 | Carboplatin + Paclitaxel (weekly) | 02 | Y | 330014166 | CARBOPLATIN + PACLITAXEL |
| 330008051 | 330004843 | 1.64 | null | Curative (C) | 2014-12-16 | 2014-12-16 | ALL UKALL 2011 HD MtxB (Protocol M) | 02 | N | 330014166 | UKALL2011 |
| 330008053 | 330004845 | null | null | null | null | 2015-01-27 | BENDAMUSTINE + RITUXIMAB | null | null | 330014197 | BENDAMUSTINE + RITUXIMAB |
| 330008056 | 330004847 | null | 46.5 | Adjuvant (A) | 2015-12-22 | 2016-07-05 | CARBOPLATIN + PACLITAXEL | 2 | null | 330014266 | CARBOPLATIN + PACLITAXEL |
| 330008057 | 330004847 | 0.52 | null | Curative (C) | 2015-12-14 | 2016-03-13 | CETUXIMAB + RT | 2 | N | 330014266 | CETUXIMAB + RT |
| 330008058 | 330004849 | 1.81 | 21.4 | Palliative (P) | 2014-01-16 | 2015-02-01 | CARBOPLATIN + FLUOROURACIL | N | N | 330014284 | CARBO + FLUOROURACIL |
| 330008059 | 330008648 | 1.77 | 89.3 | Neo-adjuvant (N) | 2017-05-11 | 2017-05-21 | ALL UKALL2011 Std BFM Cons B | N | N | 330014292 | UKALL2011 |
| 330008060 | 330010688 | 1.58 | 22.3 | Palliative (P) | 2016-11-06 | 2016-11-06 | EURAMOS TRIAL | N | N | 330014295 | EURAMOS TRIAL |
| 330008061 | 330004855 | 1.77 | 103.2 | Palliative (P) | 2015-06-15 | 2015-06-16 | CARBOPLATIN + PACLITAXEL | N | N | 330014295 | CARBOPLATIN + PACLITAXEL |
| 330008062 | 330004857 | 1 | 60.2 | null | 2014-01-18 | 2014-02-26 | CETUXIMAB + RT | null | null | 330014340 | CETUXIMAB + RT |
| 330008063 | 330004857 | 1.61 | 54.6 | null | 2016-04-25 | 2016-11-13 | ALL UKALL2011 Std Int Maint A | N | N | 330014340 | UKALL2011 |
| 330008064 | 330004858 | 1.84 | null | Curative (C) | 2017-09-16 | 2017-11-23 | VAI (Ifos 3g/m2) | N | N | 330014353 | VAI |
| 330008065 | 330004859 | 1.66 | 51.7 | null | 2015-01-22 | 2015-04-05 | CARBOPLATIN + RT | 02 | N | 330014355 | CARBOPLATIN + RT |
| 330008066 | 330008653 | 1.8 | 99.6 | Palliative (P) | 2015-03-05 | 2015-03-08 | CARBO + FLUOROURACIL | N | N | 330014355 | CARBO + FLUOROURACIL |
| 330008067 | 330008654 | null | 8.6 | Disease modification (D) | 2014-05-10 | 2014-05-10 | ALL UKALL 2011 HD MtxB (Protocol M) | N | Y | 330014373 | UKALL2011 |
| 330008068 | 330012466 | null | null | Not known (9) | 2013-11-13 | 2014-01-13 | Carbo F | N | N | 330014385 | CARBO + FLUOROURACIL |
| 330008071 | 330004865 | 1.62 | 71.6 | Palliative (P) | null | 2014-06-25 | Cetuximab + Radiotherapy Maint | Y | N | 330014444 | CETUXIMAB + RT |
| 330008072 | 330008658 | 1.53 | 54.55 | Palliative (P) | 2013-05-28 | 2014-01-05 | Paclitaxel 7 day | 02 | N | 330014444 | PACLITAXEL |
| 330008073 | 330012467 | 1.71 | 74.15 | Not known (9) | 2017-06-09 | 2017-06-13 | CARBOPLATIN + RT | N | N | 330014446 | CARBOPLATIN + RT |
| 330008074 | 330004867 | 1.83 | 54.55 | null | 2013-03-19 | 2013-03-20 | CARBOPLATIN + RT | N | null | 330014457 | CARBOPLATIN + RT |
| 330008076 | 330004869 | 1.6 | 55.7 | Curative (C) | 2013-05-01 | 2013-05-29 | Bendamustine+Rituximab (1st Course) | N | Y | 330014479 | BENDAMUSTINE + RITUXIMAB |
| 330008077 | 330004869 | 1.58 | 36.1 | Curative (C) | 2017-02-21 | 2017-02-27 | Bendamustine+Rituximab(Sub Courses) | N | N | 330014479 | BENDAMUSTINE + RITUXIMAB |
| 330008082 | 330004873 | 0 | 89.7 | Disease modification (D) | 2017-06-07 | 2017-06-29 | VAI (Ifos 3g/m2) | 01 | N | 330014539 | VAI |
| 330008085 | 330008663 | 1.6 | 54 | Curative (C) | 2013-07-17 | 2013-07-17 | Cetuximab + Radiotherapy Maint | N | N | 330014546 | CETUXIMAB + RT |
| 330008086 | 330004877 | 1.81 | 59 | Palliative (P) | 2016-01-05 | 2016-01-09 | Cisplatin + Docetaxel +Fluorouracil | 02 | N | 330014546 | CISPLATIN + DOCETAXEL + FLUOROURACIL |